A detailed history of Aqr Capital Management LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 12,221 shares of KPTI stock, worth $7,821. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,221
Previous 748,020 98.37%
Holding current value
$7,821
Previous $650,000 98.46%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.06 $515,059 - $779,946
-735,799 Reduced 98.37%
12,221 $10,000
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.58 $541,308 - $983,066
622,194 Added 494.49%
748,020 $650,000
Q1 2024

May 15, 2024

SELL
$0.72 - $1.66 $340,067 - $784,044
-472,316 Reduced 78.96%
125,826 $189,000
Q4 2023

Feb 14, 2024

BUY
$0.68 - $1.31 $65,513 - $126,209
96,343 Added 19.2%
598,142 $514,000
Q3 2023

Nov 14, 2023

BUY
$1.14 - $1.81 $385,047 - $611,347
337,761 Added 205.9%
501,799 $672,000
Q2 2023

Aug 14, 2023

BUY
$1.79 - $4.59 $149,509 - $383,379
83,525 Added 103.74%
164,038 $293,000
Q1 2023

May 15, 2023

BUY
$2.84 - $3.92 $53,579 - $73,954
18,866 Added 30.6%
80,513 $313,000
Q4 2022

Feb 14, 2023

SELL
$2.48 - $5.93 $126,551 - $302,601
-51,029 Reduced 45.29%
61,647 $209,000
Q3 2022

Nov 14, 2022

BUY
$4.08 - $5.82 $367,420 - $524,114
90,054 Added 398.08%
112,676 $615,000
Q2 2022

Aug 15, 2022

SELL
$4.15 - $8.37 $21,613 - $43,590
-5,208 Reduced 18.71%
22,622 $102,000
Q1 2022

May 16, 2022

BUY
$5.91 - $14.38 $164,475 - $400,195
27,830 New
27,830 $205,000
Q4 2020

Feb 16, 2021

SELL
$14.15 - $17.19 $1.24 Million - $1.51 Million
-87,761 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$14.14 - $19.71 $47,510 - $66,225
-3,360 Reduced 3.69%
87,761 $1.28 Million
Q2 2020

Aug 17, 2020

BUY
$16.6 - $25.25 $521,356 - $793,026
31,407 Added 52.6%
91,121 $1.73 Million
Q1 2020

May 15, 2020

BUY
$14.38 - $27.72 $691,965 - $1.33 Million
48,120 Added 415.04%
59,714 $1.15 Million
Q4 2019

Feb 14, 2020

BUY
$9.23 - $19.67 $107,012 - $228,053
11,594 New
11,594 $222,000
Q1 2019

May 14, 2019

SELL
$4.12 - $10.25 $105,455 - $262,359
-25,596 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$8.2 - $16.95 $42,402 - $87,648
-5,171 Reduced 16.81%
25,596 $240,000
Q3 2018

Nov 15, 2018

BUY
$17.03 - $21.18 $197,786 - $245,984
11,614 Added 60.64%
30,767 $524,000
Q2 2018

Aug 14, 2018

BUY
$12.0 - $19.88 $229,836 - $380,761
19,153 New
19,153 $325,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.